glp-1 kidney function receptor agonists and next-generation metabolic hormone therapies in chronic disease Recommendations for SGLT2i versus GLP-1

As with all medications in the GLP-1 receptor agonist class, retatrutide is associated with a range of gastrointestinal side effects , which were the most commonly reported adverse events in Phase 2 trials

GLP-1 Products have achieved massive growth: By the end of 2024, these GLP-1 products had a cumulative $71 billion in U.S

But as their popularity grows, so does the research into long-term side effects of GLP-1 medications

HF is directly related to the thickening and stiffening of the arteries as the results of, for example, atherosclerosis

For example, weight loss drugs are excluded from coverage from the government programs Medicaid and Medicare

Alternative: DEA take-back events The Drug Enforcement Administration holds periodic National Prescription Drug Take-Back events